162 related articles for article (PubMed ID: 30284298)
1. Neprilysin levels at the acute phase of ST-elevation myocardial infarction.
Bernelin H; Mewton N; Si-Mohamed S; Croisille P; Rioufol G; Bonnefoy-Cudraz E; Douek P; Dufay N; Amaz C; Jossan C; Ovize M; Bochaton T
Clin Cardiol; 2019 Jan; 42(1):32-38. PubMed ID: 30284298
[TBL] [Abstract][Full Text] [Related]
2. ST2 and left ventricular remodeling after ST-segment elevation myocardial infarction: A cardiac magnetic resonance study.
Miñana G; Núñez J; Bayés-Genís A; Revuelta-López E; Ríos-Navarro C; Núñez E; Chorro FJ; López-Lereu MP; Monmeneu JV; Lupón J; Bodí V
Int J Cardiol; 2018 Nov; 270():336-342. PubMed ID: 29954670
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Implications of Global Longitudinal Strain by Feature-Tracking Cardiac Magnetic Resonance in ST-Elevation Myocardial Infarction.
Reindl M; Tiller C; Holzknecht M; Lechner I; Beck A; Plappert D; Gorzala M; Pamminger M; Mayr A; Klug G; Bauer A; Metzler B; Reinstadler SJ
Circ Cardiovasc Imaging; 2019 Nov; 12(11):e009404. PubMed ID: 31679391
[TBL] [Abstract][Full Text] [Related]
4. Serum neprilysin levels are associated with myocardial stunning after ST-elevation myocardial infarction.
Legallois D; Macquaire C; Hodzic A; Allouche S; El Khouakhi I; Manrique A; Milliez P; Saloux E; Beygui F
BMC Cardiovasc Disord; 2020 Jul; 20(1):316. PubMed ID: 32615924
[TBL] [Abstract][Full Text] [Related]
5. Impact of left ventricular hypertrophy on myocardial injury in patients with ST-segment elevation myocardial infarction.
Stiermaier T; Pöss J; Eitel C; de Waha S; Fuernau G; Desch S; Thiele H; Eitel I
Clin Res Cardiol; 2018 Nov; 107(11):1013-1020. PubMed ID: 29766285
[TBL] [Abstract][Full Text] [Related]
6. High Serum Secreted Frizzled-Related Protein 5 Levels Associates with Early Improvement of Cardiac Function Following ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention.
Du Y; Zhao Y; Zhu Y; Hu C; Zhang J; Ji Q; Liu W; Han H; Yang L; Zhang D; Tong S; Wang Z; Guo Y; Liu X; Zhou Y
J Atheroscler Thromb; 2019 Oct; 26(10):868-878. PubMed ID: 30773518
[TBL] [Abstract][Full Text] [Related]
7. Association of Myocardial Injury With Serum Procalcitonin Levels in Patients With ST-Elevation Myocardial Infarction.
Reindl M; Tiller C; Holzknecht M; Lechner I; Henninger B; Mayr A; Brenner C; Klug G; Bauer A; Metzler B; Reinstadler SJ
JAMA Netw Open; 2020 Jun; 3(6):e207030. PubMed ID: 32539151
[TBL] [Abstract][Full Text] [Related]
8. Estimating the extent of myocardial damage in patients with STEMI using the DETERMINE score.
Tiller C; Holzknecht M; Reindl M; Lechner I; Kalles V; Troger F; Schwaiger J; Mayr A; Klug G; Brenner C; Bauer A; Metzler B; Reinstadler SJ
Open Heart; 2021 Feb; 8(1):. PubMed ID: 33547223
[TBL] [Abstract][Full Text] [Related]
9. High levels of interleukin-6 are associated with final infarct size and adverse clinical events in patients with STEMI.
Tøllefsen IM; Shetelig C; Seljeflot I; Eritsland J; Hoffmann P; Andersen GØ
Open Heart; 2021 Dec; 8(2):. PubMed ID: 34933964
[TBL] [Abstract][Full Text] [Related]
10. Impact of infarct location and size on clinical outcome after ST-elevation myocardial infarction treated by primary percutaneous coronary intervention.
Reindl M; Holzknecht M; Tiller C; Lechner I; Schiestl M; Simma F; Pamminger M; Henninger B; Mayr A; Klug G; Bauer A; Metzler B; Reinstadler SJ
Int J Cardiol; 2020 Feb; 301():14-20. PubMed ID: 31761400
[TBL] [Abstract][Full Text] [Related]
11. Circadian variation in acute myocardial infarct size assessed by cardiovascular magnetic resonance in reperfused STEMI patients.
Bulluck H; Nicholas J; Crimi G; White SK; Ludman AJ; Pica S; Raineri C; Cabrera-Fuentes HA; Yellon D; Rodriguez-Palomares J; Garcia-Dorado D; Hausenloy DJ
Int J Cardiol; 2017 Mar; 230():149-154. PubMed ID: 28038815
[TBL] [Abstract][Full Text] [Related]
12. Relation of inflammatory markers with myocardial and microvascular injury in patients with reperfused ST-elevation myocardial infarction.
Reindl M; Reinstadler SJ; Feistritzer HJ; Klug G; Tiller C; Mair J; Mayr A; Jaschke W; Metzler B
Eur Heart J Acute Cardiovasc Care; 2017 Oct; 6(7):640-649. PubMed ID: 27440935
[TBL] [Abstract][Full Text] [Related]
13. High-sensitivity troponin T for prediction of left ventricular function and infarct size one year following ST-elevation myocardial infarction.
Reinstadler SJ; Feistritzer HJ; Klug G; Mair J; Tu AM; Kofler M; Henninger B; Franz WM; Metzler B
Int J Cardiol; 2016 Jan; 202():188-93. PubMed ID: 26397408
[TBL] [Abstract][Full Text] [Related]
14. The contemporary value of peak creatine kinase-MB after ST-segment elevation myocardial infarction above other clinical and angiographic characteristics in predicting infarct size, left ventricular ejection fraction, and mortality.
Hartman MHT; Eppinga RN; Vlaar PJJ; Lexis CPH; Lipsic E; Haeck JDE; van Veldhuisen DJ; van der Horst ICC; van der Harst P
Clin Cardiol; 2017 May; 40(5):322-328. PubMed ID: 28026027
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the longitudinal changes in infarct heterogeneity post myocardial infarction.
Roifman I; Ghugre NR; Vira T; Zia MI; Zavodni A; Pop M; Connelly KA; Wright GA
BMC Cardiovasc Disord; 2016 Oct; 16(1):198. PubMed ID: 27741939
[TBL] [Abstract][Full Text] [Related]
17. Association of Circulating Ketone Bodies With Functional Outcomes After ST-Segment Elevation Myocardial Infarction.
de Koning MLY; Westenbrink BD; Assa S; Garcia E; Connelly MA; van Veldhuisen DJ; Dullaart RPF; Lipsic E; van der Harst P
J Am Coll Cardiol; 2021 Oct; 78(14):1421-1432. PubMed ID: 34593124
[TBL] [Abstract][Full Text] [Related]
18. Impact of direct stenting on myocardial injury assessed by cardiac magnetic resonance imaging and prognosis in ST-elevation myocardial infarction.
Saad M; Stiermaier T; Fuernau G; Pöss J; de Waha-Thiele S; Desch S; Thiele H; Eitel I
Int J Cardiol; 2019 May; 283():88-92. PubMed ID: 30573280
[TBL] [Abstract][Full Text] [Related]
19. Myocardial Damage in Patients With Deferred Stenting After STEMI: A DANAMI-3-DEFER Substudy.
Lønborg J; Engstrøm T; Ahtarovski KA; Nepper-Christensen L; Helqvist S; Vejlstrup N; Kyhl K; Schoos MM; Ghotbi A; Göransson C; Bertelsen L; Holmvang L; Pedersen F; Jørgensen E; Saunamäki K; Clemmensen P; De Backer O; Kløvgaard L; Høfsten DE; Køber L; Kelbæk H;
J Am Coll Cardiol; 2017 Jun; 69(23):2794-2804. PubMed ID: 28595694
[TBL] [Abstract][Full Text] [Related]
20. Impact of multivessel coronary artery disease on reperfusion success in patients with ST-elevation myocardial infarction: A substudy of the AIDA STEMI trial.
de Waha S; Eitel I; Desch S; Fuernau G; Pöss J; Schuler G; Thiele H
Eur Heart J Acute Cardiovasc Care; 2017 Oct; 6(7):592-600. PubMed ID: 26691729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
